Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records
Jas Bindra,1 Ishveen Chopra,2 Kyle Hayes,3 John Niewoehner,3 Mary Prince Panaccio,3 George J Wan3 1Falcon Research Group, North Potomac, MD, USA; 2Manticore Consultancy, Bethesda, MD, USA; 3Mallinckrodt Pharmaceuticals, Bridgewater, NJ, USACorrespondence: George J Wan, Mallinckrodt Pharmaceuticals,...
Saved in:
Main Authors: | Bindra J (Author), Chopra I (Author), Hayes K (Author), Niewoehner J (Author), Panaccio MP (Author), Wan GJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis
by: Bindra J, et al.
Published: (2023) -
Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence
by: Wan GJ, et al.
Published: (2023) -
Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis
by: Hunter SF, et al.
Published: (2021) -
Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
by: Bindra J, et al.
Published: (2021) -
African American Primary Care Physicians' Prostate Cancer Screening Practices
by: Louie E. Ross, et al.
Published: (2014)